CONMED Corp. Stock
CONMED Corp. Stock
CONMED Corp. shows a slight decrease today, losing -€0.200 (-0.510%) compared to yesterday.
Our community is currently high on CONMED Corp. with 3 Buy predictions and 0 Sell predictions.
As a result the target price of 53 € shows a positive potential of 36.6% compared to the current price of 38.8 € for CONMED Corp..
Pros and Cons of CONMED Corp. in the next few years
Pros
?
S********** s********
?
B****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of CONMED Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| CONMED Corp. | -0.510% | 1.571% | 20.497% | -31.930% | 10.857% | -57.127% | -62.330% |
| Neogen Corp. | -0.520% | -0.518% | 10.983% | -1.031% | 56.098% | - | - |
| Glaukos Corp | 0.970% | 3.518% | 1.980% | -9.649% | 4.569% | 121.983% | 29.560% |
| Integra LifeSciences Holdings Corp | 0.520% | -6.796% | 2.674% | -56.364% | -9.434% | -81.359% | -83.158% |
Comments
CONMED (NYSE:CNMD) had its price target lowered by analysts at Piper Sandler from $68.00 to $55.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat
CONMED Corporation (NYSE: CNMD) had its price target lowered by analysts at Piper Sandler from $80.00 to $68.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Needham & Company LLC from $91.00 to $61.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat